Alan Hartford to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Alan Hartford has written about Dose-Response Relationship, Drug.
Connection Strength
0.159
-
Zhou Y, Chen S, Sullivan D, Li Y, Zhang Y, Xie W, Zhang H, Tang Y, Wang L, Hartford A, Yang B. Dose-ranging design and analysis methods to identify the minimum effective dose (MED). Contemp Clin Trials. 2017 12; 63:59-66.
Score: 0.125
-
Lieberman FS, Wang M, Robins HI, Tsien CI, Curran WJ, Werner-Wasik M, Smith RP, Schultz C, Hartford AC, Zhang P, Mehta MP. Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):878-886.
Score: 0.034